James C. Wade, MD

Articles by James C. Wade, MD

Current Issues in the Treatment of Resistant Bloodstream Infections

ByJames C. Wade, MD,Donald H. Batts, MD,John N. Greene, MD,David C. Linch, MD,Georg Maschmeyer, MD, PhD,Carole B. Miller, MD,Gary A. Noskin, MD,Patricia Ribaud, MD,Kenneth V. I. Rolston, MD,Kent A. Sepkowitz, MD,James A. Talcott, MD

August 1st 2000

Bloodstream infections cause significant morbidity and mortality for patients with hematologic malignancy. Antimicrobial drugs are the most reliable currently available treatment for infection, but several issues must be

Latest Updated Articles

Current Issues in the Treatment of Resistant Bloodstream Infections
Published: August 1st 2000 | Updated:

James C. Wade, MD

Articles by James C. Wade, MD

Current Issues in the Treatment of Resistant Bloodstream Infections

Latest Updated Articles

Trending on CancerNetwork

FDA Issues CRL for Dasatinib in CML/ALL

FDA Accepts Resubmission of BLA for RP1/Nivolumab in Advanced Melanoma

Raludotatug Deruxtecan Shows Promise in Platinum-Resistant Ovarian Cancer

Patient With RRMM, Cytopenias, COPD, and Progressive Bone Disease

Why is Radiotherapy Not More Accessible as a Cancer Treatment?